Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual isosorbide dinitrate plus indomethacin for prevention of post-ERCP pancreatitis
IRCT138810082931N1Phase 3Completed
- Sponsor
- Digestive disease research center
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of isosorbide dinitrate and indomethacin in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Digestive disease research center. Started Feb 2011; status: completed.
02
Drugs
isosorbide dinitrateindomethacin
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on IRCT138810082931N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138810082931N1.